Has Avishek Kumar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $15,795 in general payments to Avishek Kumar, MD across 414 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Avishek Kumar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Avishek Kumar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Avishek Kumar, MD

Hematology & Oncology · Edison, NJNPI 1700171691

Payments from drug & device makers

$15,795in general payments, 2019–2025

Across 414 payments — averaging $38.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pharmacosmos Therapeutics Inc.$8K
E.r. Squibb & Sons, L.L.C.$963
Amgen$646
Johnson & Johnson$548
AstraZeneca$519
Incyte Corporation$384
plus $5K from 54 others

What the payments were for

Speaking & faculty fees$7,70449%
Travel & lodging$70%
Food & beverage$7,01444%
Education$1,0697%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pharmacosmos Therapeutics Inc.	11	$8,101
E.r. Squibb & Sons, L.L.C.	60	$963
Amgen	33	$646
Johnson & Johnson(2 entities)	28	$548
AstraZeneca(2 entities)	28	$519
Incyte Corporation	13	$384
Daiichi Sankyo Inc.	17	$355
Eisai Inc.	10	$275
Gilead(2 entities)	17	$270
Pfizer	18	$262
Novartis	16	$239
Regeneron Healthcare Solutions, Inc.	13	$207
Seagen Inc.	7	$192
Takeda Pharmaceuticals U.S.A., Inc.	7	$190
Sirtex Medical Inc	1	$187
Bayer	9	$162
Bristol Myers Squibb	11	$161
AVEO Pharmaceuticals, Inc.	5	$145
Astellas Pharma US Inc	9	$133
Array Biopharma Inc	6	$104
Genentech USA, Inc.	6	$100
AbbVie	5	$97
Lilly USA, LLC	6	$97
EMD Serono, Inc.	5	$77
Boston Scientific	1	$76
Adaptive Biotechnologies Corporation	3	$72
Novo Nordisk	1	$69
Sanofi	4	$65
Exelixis Inc.	4	$62
Merck	4	$60
Tempus AI, Inc	3	$59
Taiho Oncology, Inc.	3	$52
Puma Biotechnology, Inc.	3	$50
Boehringer Ingelheim	3	$49
Ipsen Biopharmaceuticals, Inc	3	$48
Geron Corporation	3	$48
Spectrum Pharmaceuticals Inc.	1	$48
Pharmacyclics LLC, An Abbvie Company	2	$47
Jazz Pharmaceuticals Inc.	2	$47
GSK	3	$46
Dendreon Pharmaceuticals LLC	2	$37
Beone Medicines USA, Inc.	2	$32
Acrotech Biopharma Inc.	2	$30
Rigel Pharmaceuticals, Inc.	2	$28
Coherus Oncology, Inc.	2	$27
Global Blood Therapeutics, Inc.	2	$24
Lexicon Pharmaceuticals, Inc.	1	$24
Teva Pharmaceuticals USA, Inc.	1	$20
Lundbeck LLC	1	$19
Invivyd Inc	1	$19
Deciphera Pharmaceuticals Inc.	1	$18
Blueprint Medicines Corporation	1	$18
Sobi, Inc	1	$18
Mylan Institutional Inc.	1	$17
Apellis Pharmaceuticals, Inc.	1	$17
Servier Pharmaceuticals LLC	1	$16
Pharmaessentia USA Corporation	1	$16
Octapharma USA, Inc.	1	$16
Foundation Medicine, Inc.	1	$16
Dova Pharmaceuticals	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,795 in reported general payments places this provider in the 60th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$1,195,463

Medicare patients

177

Services billed

78,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Anastrozole	25	$358

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Edison

Bruno FangEast Brunswick$8.5M
Charles FarberMorristown$4.6M
Rajat BannerjiNew Brunswick$3.3M
Eleonora TeplinskyParamus$2.6M
Mohamad CherryMorristown$1.9M
Evan NaylorManahawkin$1.3M
James OrsiniBelleville$1.3M
Eli KirshnerWestwood$1.2M
Linda DanieuLivingston$1.2M
Steven PapishMorristown$1.2M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →